Brenda Beaty
Concepts (518)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 56 | 2022 | 1202 | 2.960 |
Why?
| Attitude of Health Personnel | 34 | 2021 | 970 | 1.920 |
Why?
| Practice Patterns, Physicians' | 36 | 2021 | 1175 | 1.910 |
Why?
| Physicians, Primary Care | 14 | 2021 | 222 | 1.660 |
Why?
| Influenza Vaccines | 24 | 2021 | 497 | 1.460 |
Why?
| Immunization | 20 | 2021 | 397 | 1.460 |
Why?
| Reminder Systems | 13 | 2021 | 159 | 1.250 |
Why?
| Health Knowledge, Attitudes, Practice | 24 | 2021 | 1168 | 1.190 |
Why?
| Vaccines | 15 | 2021 | 375 | 1.180 |
Why?
| Immunization Programs | 18 | 2020 | 204 | 1.180 |
Why?
| Papillomavirus Vaccines | 12 | 2021 | 222 | 1.080 |
Why?
| Influenza, Human | 18 | 2021 | 543 | 1.060 |
Why?
| Pediatrics | 24 | 2021 | 981 | 1.050 |
Why?
| Physicians, Family | 13 | 2021 | 201 | 0.960 |
Why?
| Primary Health Care | 22 | 2021 | 1502 | 0.930 |
Why?
| Pediatricians | 8 | 2022 | 122 | 0.890 |
Why?
| Papillomavirus Infections | 8 | 2021 | 261 | 0.760 |
Why?
| Pneumococcal Vaccines | 8 | 2021 | 131 | 0.690 |
Why?
| Vaccination Refusal | 5 | 2021 | 69 | 0.680 |
Why?
| Stifle | 1 | 2019 | 4 | 0.660 |
Why?
| Patellar Ligament | 1 | 2019 | 22 | 0.640 |
Why?
| Dog Diseases | 1 | 2019 | 41 | 0.630 |
Why?
| Anterior Cruciate Ligament | 1 | 2019 | 79 | 0.620 |
Why?
| Health Care Surveys | 18 | 2021 | 541 | 0.620 |
Why?
| Herpes Zoster Vaccine | 6 | 2022 | 159 | 0.600 |
Why?
| Mumps | 3 | 2023 | 23 | 0.590 |
Why?
| Osteotomy | 1 | 2019 | 143 | 0.580 |
Why?
| Surveys and Questionnaires | 33 | 2022 | 4598 | 0.580 |
Why?
| Anterior Cruciate Ligament Injuries | 1 | 2019 | 130 | 0.560 |
Why?
| Female | 105 | 2022 | 59346 | 0.520 |
Why?
| Humans | 157 | 2023 | 114075 | 0.510 |
Why?
| Male | 94 | 2021 | 55416 | 0.490 |
Why?
| Family Practice | 11 | 2017 | 426 | 0.490 |
Why?
| United States | 47 | 2021 | 12143 | 0.470 |
Why?
| Physicians | 11 | 2022 | 765 | 0.470 |
Why?
| Parents | 10 | 2021 | 1181 | 0.460 |
Why?
| Herpes Zoster | 4 | 2022 | 330 | 0.450 |
Why?
| Rotavirus Vaccines | 4 | 2021 | 48 | 0.430 |
Why?
| Middle Aged | 56 | 2021 | 26620 | 0.430 |
Why?
| Immunization Schedule | 6 | 2021 | 183 | 0.430 |
Why?
| Adult | 59 | 2022 | 30394 | 0.420 |
Why?
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 7 | 2019 | 89 | 0.420 |
Why?
| Insurance, Health, Reimbursement | 6 | 2018 | 88 | 0.410 |
Why?
| Rubella | 2 | 2023 | 21 | 0.410 |
Why?
| Measles | 2 | 2023 | 38 | 0.400 |
Why?
| Terminally Ill | 3 | 2007 | 33 | 0.390 |
Why?
| Rotavirus Infections | 4 | 2021 | 50 | 0.380 |
Why?
| Hypertension | 7 | 2016 | 1052 | 0.370 |
Why?
| Colorado | 33 | 2020 | 4092 | 0.360 |
Why?
| Meningococcal Vaccines | 4 | 2018 | 48 | 0.340 |
Why?
| Community Health Services | 4 | 2017 | 212 | 0.340 |
Why?
| Pregnancy Complications, Infectious | 3 | 2020 | 285 | 0.330 |
Why?
| Infant | 36 | 2022 | 7944 | 0.330 |
Why?
| Child | 40 | 2023 | 18407 | 0.330 |
Why?
| Patient Acceptance of Health Care | 7 | 2016 | 678 | 0.320 |
Why?
| Organ Transplantation | 2 | 2023 | 159 | 0.310 |
Why?
| Anesthesia, Obstetrical | 2 | 1998 | 6 | 0.300 |
Why?
| Stress, Psychological | 4 | 2014 | 944 | 0.300 |
Why?
| Gynecology | 3 | 2019 | 163 | 0.290 |
Why?
| Hospitalization | 6 | 2020 | 1762 | 0.290 |
Why?
| Internal Medicine | 5 | 2014 | 211 | 0.270 |
Why?
| Clinical Competence | 3 | 2018 | 882 | 0.270 |
Why?
| Liver Transplantation | 3 | 2019 | 695 | 0.270 |
Why?
| Respiratory Syncytial Virus Infections | 2 | 2018 | 97 | 0.270 |
Why?
| Practice Guidelines as Topic | 10 | 2021 | 1381 | 0.250 |
Why?
| Emergency Medical Services | 2 | 2023 | 583 | 0.250 |
Why?
| Aged | 29 | 2021 | 18973 | 0.240 |
Why?
| Adolescent | 28 | 2023 | 17810 | 0.240 |
Why?
| Insurance, Health | 5 | 2016 | 243 | 0.240 |
Why?
| Child, Preschool | 26 | 2023 | 9118 | 0.240 |
Why?
| Urban Population | 4 | 2017 | 396 | 0.230 |
Why?
| Physician-Patient Relations | 3 | 2019 | 459 | 0.230 |
Why?
| Pneumococcal Infections | 3 | 2018 | 91 | 0.230 |
Why?
| Cohort Studies | 19 | 2023 | 4884 | 0.230 |
Why?
| Professional-Family Relations | 2 | 2016 | 131 | 0.230 |
Why?
| Multivariate Analysis | 13 | 2020 | 1422 | 0.220 |
Why?
| Adolescent Health Services | 3 | 2015 | 68 | 0.220 |
Why?
| Delivery of Health Care | 5 | 2012 | 828 | 0.220 |
Why?
| General Practitioners | 2 | 2021 | 23 | 0.210 |
Why?
| Shock, Traumatic | 1 | 2023 | 15 | 0.210 |
Why?
| Registries | 10 | 2022 | 1764 | 0.210 |
Why?
| Child Health Services | 5 | 2007 | 175 | 0.210 |
Why?
| Viral Vaccines | 1 | 2023 | 88 | 0.200 |
Why?
| Chickenpox | 1 | 2023 | 93 | 0.200 |
Why?
| Attitude to Health | 2 | 2017 | 398 | 0.200 |
Why?
| Pain | 3 | 2009 | 701 | 0.200 |
Why?
| Vaccines, Synthetic | 2 | 2022 | 124 | 0.200 |
Why?
| Health Promotion | 5 | 2015 | 675 | 0.200 |
Why?
| Data Collection | 12 | 2014 | 618 | 0.200 |
Why?
| Text Messaging | 2 | 2022 | 152 | 0.190 |
Why?
| Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.190 |
Why?
| Follow-Up Studies | 8 | 2019 | 4392 | 0.190 |
Why?
| Prisoners | 2 | 2014 | 124 | 0.190 |
Why?
| Insurance Coverage | 5 | 2018 | 199 | 0.190 |
Why?
| Health Services Accessibility | 6 | 2019 | 756 | 0.190 |
Why?
| Sexually Transmitted Diseases | 3 | 2013 | 154 | 0.180 |
Why?
| Alphapapillomavirus | 1 | 2021 | 36 | 0.180 |
Why?
| Hepatitis B Vaccines | 3 | 2010 | 46 | 0.180 |
Why?
| Treatment Refusal | 2 | 2015 | 85 | 0.180 |
Why?
| Breast Feeding | 4 | 2022 | 366 | 0.180 |
Why?
| Health Care Costs | 2 | 2017 | 381 | 0.180 |
Why?
| Refusal to Treat | 1 | 2020 | 18 | 0.180 |
Why?
| Mobile Applications | 1 | 2022 | 140 | 0.170 |
Why?
| Retrospective Studies | 18 | 2019 | 12521 | 0.170 |
Why?
| Standing Orders | 1 | 2020 | 11 | 0.170 |
Why?
| Advisory Committees | 1 | 2021 | 207 | 0.170 |
Why?
| Norovirus | 1 | 2020 | 23 | 0.170 |
Why?
| Cost-Benefit Analysis | 7 | 2019 | 544 | 0.160 |
Why?
| Resuscitation Orders | 1 | 2020 | 45 | 0.160 |
Why?
| Obstetrics | 2 | 2019 | 146 | 0.160 |
Why?
| Antihypertensive Agents | 3 | 2012 | 428 | 0.160 |
Why?
| Wounds and Injuries | 2 | 2022 | 674 | 0.160 |
Why?
| Policy | 1 | 2020 | 137 | 0.160 |
Why?
| School Health Services | 3 | 2012 | 206 | 0.160 |
Why?
| Patient Protection and Affordable Care Act | 2 | 2016 | 99 | 0.160 |
Why?
| Gastroenteritis | 1 | 2020 | 65 | 0.160 |
Why?
| Internet | 7 | 2019 | 591 | 0.160 |
Why?
| State Health Plans | 3 | 2005 | 32 | 0.160 |
Why?
| Patient Participation | 2 | 2012 | 348 | 0.160 |
Why?
| Blood Vessels | 2 | 2016 | 179 | 0.150 |
Why?
| Pneumonia, Aspiration | 1 | 1998 | 15 | 0.150 |
Why?
| Public Health Practice | 2 | 2012 | 61 | 0.150 |
Why?
| Respiratory Syncytial Virus Vaccines | 1 | 2018 | 24 | 0.150 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 138 | 0.150 |
Why?
| Echocardiography, Stress | 1 | 2018 | 20 | 0.150 |
Why?
| Health Services Research | 5 | 2018 | 373 | 0.150 |
Why?
| Myocardial Perfusion Imaging | 1 | 2018 | 34 | 0.150 |
Why?
| Postoperative Period | 1 | 2019 | 288 | 0.150 |
Why?
| Hospital Costs | 1 | 2019 | 104 | 0.150 |
Why?
| Dogs | 1 | 2019 | 331 | 0.150 |
Why?
| Chronic Disease | 7 | 2016 | 1578 | 0.150 |
Why?
| Meningococcal Infections | 1 | 2018 | 20 | 0.150 |
Why?
| Automobile Driver Examination | 1 | 2017 | 10 | 0.150 |
Why?
| Tibia | 1 | 2019 | 166 | 0.150 |
Why?
| Public Health | 4 | 2015 | 435 | 0.150 |
Why?
| Pregnant Women | 1 | 2019 | 126 | 0.140 |
Why?
| Prospective Studies | 10 | 2022 | 6198 | 0.140 |
Why?
| Professional Practice | 1 | 2018 | 63 | 0.140 |
Why?
| Kidney Transplantation | 1 | 2023 | 538 | 0.140 |
Why?
| Herpesvirus 3, Human | 2 | 2019 | 377 | 0.140 |
Why?
| Private Practice | 3 | 2012 | 20 | 0.140 |
Why?
| Guideline Adherence | 5 | 2016 | 489 | 0.140 |
Why?
| Cross Infection | 1 | 2019 | 194 | 0.140 |
Why?
| Croup | 1 | 2017 | 22 | 0.140 |
Why?
| Hepatitis A | 1 | 2017 | 26 | 0.140 |
Why?
| Myocardial Ischemia | 1 | 2018 | 239 | 0.130 |
Why?
| Physician's Role | 2 | 2019 | 192 | 0.130 |
Why?
| Regression Analysis | 6 | 2020 | 945 | 0.130 |
Why?
| Infant Mortality | 1 | 1997 | 91 | 0.130 |
Why?
| Mothers | 3 | 2022 | 650 | 0.130 |
Why?
| Biomechanical Phenomena | 1 | 2019 | 669 | 0.130 |
Why?
| Information Systems | 1 | 2016 | 61 | 0.130 |
Why?
| Heart Arrest | 1 | 2020 | 293 | 0.130 |
Why?
| Survival Rate | 5 | 2020 | 1638 | 0.130 |
Why?
| Vaccination Coverage | 1 | 2016 | 63 | 0.130 |
Why?
| Program Evaluation | 3 | 2017 | 820 | 0.130 |
Why?
| Age Factors | 7 | 2021 | 2886 | 0.130 |
Why?
| Carotid Intima-Media Thickness | 1 | 2016 | 65 | 0.130 |
Why?
| Ultrasonography | 1 | 2019 | 635 | 0.130 |
Why?
| Health Resources | 1 | 2017 | 120 | 0.130 |
Why?
| Risk Assessment | 5 | 2017 | 2958 | 0.130 |
Why?
| Health Information Systems | 1 | 2015 | 16 | 0.130 |
Why?
| Directive Counseling | 1 | 2016 | 41 | 0.130 |
Why?
| Documentation | 2 | 2015 | 166 | 0.120 |
Why?
| Local Government | 1 | 2015 | 29 | 0.120 |
Why?
| Young Adult | 12 | 2020 | 10458 | 0.120 |
Why?
| Risk-Taking | 3 | 2013 | 333 | 0.120 |
Why?
| Quality Assurance, Health Care | 3 | 2007 | 308 | 0.120 |
Why?
| Rural Population | 3 | 2014 | 443 | 0.120 |
Why?
| Computers, Handheld | 1 | 2015 | 23 | 0.120 |
Why?
| Heart Septum | 1 | 2015 | 28 | 0.120 |
Why?
| Communicable Diseases | 1 | 2017 | 127 | 0.120 |
Why?
| Cause of Death | 1 | 1997 | 362 | 0.120 |
Why?
| Ablation Techniques | 1 | 2015 | 25 | 0.120 |
Why?
| Heart Block | 1 | 2015 | 39 | 0.120 |
Why?
| Risk Factors | 13 | 2017 | 8612 | 0.120 |
Why?
| Diagnostic Tests, Routine | 1 | 2015 | 87 | 0.120 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 122 | 0.120 |
Why?
| Preventive Health Services | 1 | 2016 | 134 | 0.110 |
Why?
| Streptococcal Vaccines | 1 | 2014 | 6 | 0.110 |
Why?
| Gastroenterology | 1 | 2016 | 159 | 0.110 |
Why?
| Medically Uninsured | 4 | 2014 | 122 | 0.110 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2015 | 121 | 0.110 |
Why?
| SEER Program | 2 | 2012 | 195 | 0.110 |
Why?
| Quality of Life | 4 | 2008 | 2344 | 0.110 |
Why?
| Public-Private Sector Partnerships | 1 | 2014 | 43 | 0.110 |
Why?
| Clinical Decision-Making | 3 | 2021 | 268 | 0.110 |
Why?
| Pregnancy | 8 | 2020 | 5503 | 0.110 |
Why?
| Inpatients | 1 | 2017 | 378 | 0.110 |
Why?
| Cardiovascular Diseases | 2 | 2017 | 1726 | 0.110 |
Why?
| Palliative Care | 3 | 2008 | 641 | 0.110 |
Why?
| Disease Outbreaks | 3 | 2022 | 307 | 0.110 |
Why?
| Suicide, Attempted | 1 | 2016 | 316 | 0.100 |
Why?
| Patient Selection | 2 | 2007 | 629 | 0.100 |
Why?
| Neonatal Screening | 1 | 2014 | 151 | 0.100 |
Why?
| Referral and Consultation | 2 | 2014 | 632 | 0.100 |
Why?
| Health Education | 1 | 2015 | 317 | 0.100 |
Why?
| Disease Management | 2 | 2017 | 556 | 0.100 |
Why?
| South Africa | 2 | 2023 | 160 | 0.100 |
Why?
| Atherosclerosis | 1 | 2016 | 342 | 0.100 |
Why?
| Blood Pressure | 2 | 2016 | 1531 | 0.100 |
Why?
| Streptococcal Infections | 1 | 2014 | 127 | 0.100 |
Why?
| Electronic Mail | 3 | 2018 | 54 | 0.100 |
Why?
| Infant, Newborn | 9 | 2021 | 5038 | 0.100 |
Why?
| Vaccines, Attenuated | 2 | 2023 | 113 | 0.100 |
Why?
| Craniopharyngioma | 1 | 2012 | 65 | 0.100 |
Why?
| Developmental Disabilities | 1 | 2014 | 236 | 0.100 |
Why?
| Poverty | 6 | 2017 | 440 | 0.100 |
Why?
| Hyperlipidemias | 1 | 2012 | 121 | 0.090 |
Why?
| Attitude | 2 | 2021 | 228 | 0.090 |
Why?
| Suicidal Ideation | 1 | 2016 | 401 | 0.090 |
Why?
| Medication Adherence | 3 | 2012 | 531 | 0.090 |
Why?
| Interviews as Topic | 5 | 2014 | 576 | 0.090 |
Why?
| Continuity of Patient Care | 1 | 2013 | 252 | 0.090 |
Why?
| Critical Pathways | 1 | 2012 | 76 | 0.090 |
Why?
| Pituitary Neoplasms | 1 | 2012 | 156 | 0.090 |
Why?
| Vascular Stiffness | 1 | 2015 | 410 | 0.090 |
Why?
| Safety | 1 | 2013 | 298 | 0.090 |
Why?
| Seasons | 4 | 2020 | 440 | 0.090 |
Why?
| Patients | 2 | 2018 | 163 | 0.090 |
Why?
| Condoms | 2 | 2009 | 112 | 0.090 |
Why?
| Neoplasms | 3 | 2009 | 2088 | 0.090 |
Why?
| Acculturation | 1 | 2011 | 51 | 0.090 |
Why?
| Firearms | 1 | 2016 | 301 | 0.090 |
Why?
| Ethanol | 1 | 2015 | 534 | 0.090 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 129 | 0.090 |
Why?
| Licensure, Medical | 1 | 2010 | 12 | 0.090 |
Why?
| Child Abuse | 1 | 2015 | 456 | 0.090 |
Why?
| Albuterol | 1 | 2011 | 102 | 0.090 |
Why?
| Drug Recalls | 1 | 2010 | 5 | 0.090 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2015 | 1204 | 0.090 |
Why?
| Haemophilus Vaccines | 1 | 2010 | 27 | 0.090 |
Why?
| Haemophilus influenzae | 1 | 2010 | 48 | 0.090 |
Why?
| Haemophilus Infections | 1 | 2010 | 28 | 0.090 |
Why?
| Evidence-Based Medicine | 3 | 2020 | 662 | 0.080 |
Why?
| Medicare Part D | 1 | 2010 | 26 | 0.080 |
Why?
| Social Class | 2 | 2009 | 205 | 0.080 |
Why?
| Audiovisual Aids | 1 | 2009 | 15 | 0.080 |
Why?
| Polysaccharides, Bacterial | 1 | 2010 | 66 | 0.080 |
Why?
| Research Design | 1 | 2015 | 919 | 0.080 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2010 | 58 | 0.080 |
Why?
| Public Assistance | 1 | 2009 | 18 | 0.080 |
Why?
| Quality Improvement | 2 | 2014 | 944 | 0.080 |
Why?
| Family Nursing | 1 | 2009 | 12 | 0.080 |
Why?
| Practice Management, Medical | 1 | 2009 | 34 | 0.080 |
Why?
| Patient-Centered Care | 2 | 2013 | 470 | 0.080 |
Why?
| Aged, 80 and over | 5 | 2020 | 6307 | 0.080 |
Why?
| Cross-Sectional Studies | 8 | 2016 | 4403 | 0.080 |
Why?
| Incidence | 5 | 2017 | 2314 | 0.080 |
Why?
| Costs and Cost Analysis | 3 | 2018 | 196 | 0.080 |
Why?
| Computer-Assisted Instruction | 1 | 2009 | 59 | 0.080 |
Why?
| Sexual Behavior | 2 | 2013 | 434 | 0.080 |
Why?
| Bronchodilator Agents | 1 | 2011 | 239 | 0.080 |
Why?
| Substance-Related Disorders | 2 | 2014 | 942 | 0.080 |
Why?
| Time Factors | 8 | 2012 | 6077 | 0.080 |
Why?
| Prostatic Neoplasms | 2 | 2006 | 913 | 0.080 |
Why?
| Pain Management | 2 | 2009 | 285 | 0.080 |
Why?
| User-Computer Interface | 1 | 2009 | 141 | 0.080 |
Why?
| Logistic Models | 6 | 2012 | 1829 | 0.080 |
Why?
| Emergency Service, Hospital | 3 | 2016 | 1815 | 0.080 |
Why?
| Hepatitis B | 1 | 2009 | 51 | 0.080 |
Why?
| Fetus | 2 | 2004 | 698 | 0.080 |
Why?
| Patient Access to Records | 2 | 2005 | 20 | 0.080 |
Why?
| Condoms, Female | 1 | 2008 | 6 | 0.080 |
Why?
| Health Services Needs and Demand | 2 | 2007 | 241 | 0.080 |
Why?
| Algorithms | 1 | 2015 | 1469 | 0.080 |
Why?
| Treatment Outcome | 7 | 2023 | 9049 | 0.080 |
Why?
| Social Marketing | 1 | 2008 | 13 | 0.080 |
Why?
| Reproductive Medicine | 1 | 2008 | 15 | 0.070 |
Why?
| Massage | 1 | 2008 | 42 | 0.070 |
Why?
| Quality of Health Care | 2 | 2005 | 572 | 0.070 |
Why?
| Complementary Therapies | 1 | 2009 | 74 | 0.070 |
Why?
| Neuralgia, Postherpetic | 1 | 2008 | 44 | 0.070 |
Why?
| Sentinel Surveillance | 1 | 2008 | 38 | 0.070 |
Why?
| Alcoholism | 1 | 2014 | 710 | 0.070 |
Why?
| HIV Infections | 2 | 2013 | 2453 | 0.070 |
Why?
| Medicaid | 3 | 2021 | 404 | 0.070 |
Why?
| Diabetes Mellitus | 2 | 2012 | 898 | 0.070 |
Why?
| Drug Prescriptions | 1 | 2009 | 237 | 0.070 |
Why?
| Sex Factors | 3 | 2020 | 1707 | 0.070 |
Why?
| Hospice Care | 2 | 2007 | 184 | 0.070 |
Why?
| Proxy | 1 | 2006 | 22 | 0.070 |
Why?
| Employment | 1 | 2008 | 137 | 0.070 |
Why?
| Affect | 1 | 2008 | 246 | 0.070 |
Why?
| Terminal Care | 2 | 2006 | 212 | 0.070 |
Why?
| Social Support | 1 | 2010 | 531 | 0.060 |
Why?
| Kidney Diseases | 1 | 2009 | 349 | 0.060 |
Why?
| Vulnerable Populations | 1 | 2006 | 128 | 0.060 |
Why?
| Information Services | 1 | 2005 | 42 | 0.060 |
Why?
| Health Status Indicators | 1 | 2006 | 155 | 0.060 |
Why?
| Marital Status | 1 | 2005 | 41 | 0.060 |
Why?
| Patient Satisfaction | 2 | 2005 | 571 | 0.060 |
Why?
| Hypoglycemic Agents | 1 | 2012 | 1011 | 0.060 |
Why?
| Survivors | 1 | 2008 | 415 | 0.060 |
Why?
| Direct Service Costs | 1 | 2004 | 10 | 0.060 |
Why?
| Medical Assistance | 1 | 2004 | 13 | 0.060 |
Why?
| Chi-Square Distribution | 2 | 2018 | 492 | 0.060 |
Why?
| Postal Service | 2 | 2018 | 29 | 0.060 |
Why?
| Odds Ratio | 3 | 2013 | 951 | 0.060 |
Why?
| Socioeconomic Factors | 4 | 2011 | 1080 | 0.060 |
Why?
| Health Services | 1 | 2005 | 103 | 0.060 |
Why?
| Forms and Records Control | 1 | 2004 | 21 | 0.060 |
Why?
| Asthma | 4 | 2011 | 2021 | 0.060 |
Why?
| Vaccines, Combined | 1 | 2023 | 46 | 0.050 |
Why?
| Social Environment | 1 | 2005 | 284 | 0.050 |
Why?
| Colonoscopy | 1 | 2005 | 197 | 0.050 |
Why?
| Public Health Informatics | 1 | 2003 | 7 | 0.050 |
Why?
| Chickenpox Vaccine | 1 | 2023 | 69 | 0.050 |
Why?
| Hospices | 1 | 2004 | 83 | 0.050 |
Why?
| Ultrasonography, Prenatal | 2 | 2004 | 238 | 0.050 |
Why?
| Health Personnel | 2 | 2019 | 569 | 0.050 |
Why?
| Comparative Effectiveness Research | 2 | 2015 | 131 | 0.050 |
Why?
| Ambulances | 1 | 2023 | 48 | 0.050 |
Why?
| Health Status | 1 | 2008 | 717 | 0.050 |
Why?
| Kidney | 1 | 2009 | 1181 | 0.050 |
Why?
| Efficiency, Organizational | 1 | 2004 | 126 | 0.050 |
Why?
| Vaccines, Conjugate | 2 | 2018 | 59 | 0.050 |
Why?
| Measles-Mumps-Rubella Vaccine | 1 | 2022 | 41 | 0.050 |
Why?
| Transplant Recipients | 1 | 2023 | 136 | 0.050 |
Why?
| Medicare | 2 | 2018 | 661 | 0.050 |
Why?
| Health Surveys | 2 | 2018 | 441 | 0.050 |
Why?
| Risk Reduction Behavior | 2 | 2017 | 200 | 0.050 |
Why?
| Meconium | 1 | 2001 | 7 | 0.050 |
Why?
| Meconium Aspiration Syndrome | 1 | 2001 | 11 | 0.050 |
Why?
| Mumps Vaccine | 1 | 2021 | 13 | 0.050 |
Why?
| Educational Status | 2 | 2017 | 408 | 0.050 |
Why?
| Hospitals, Pediatric | 2 | 2015 | 478 | 0.050 |
Why?
| Nasopharynx | 1 | 2001 | 61 | 0.050 |
Why?
| Length of Stay | 3 | 2018 | 957 | 0.050 |
Why?
| Cooperative Behavior | 2 | 2015 | 376 | 0.050 |
Why?
| Milk, Human | 1 | 2022 | 127 | 0.050 |
Why?
| Health Policy | 1 | 2004 | 330 | 0.050 |
Why?
| Health Maintenance Organizations | 2 | 2012 | 93 | 0.050 |
Why?
| Animals | 3 | 2019 | 31570 | 0.050 |
Why?
| Body Composition | 1 | 2004 | 590 | 0.040 |
Why?
| Living Donors | 1 | 2023 | 270 | 0.040 |
Why?
| Vaccines, Inactivated | 1 | 2021 | 68 | 0.040 |
Why?
| Islets of Langerhans | 2 | 1996 | 728 | 0.040 |
Why?
| Prognosis | 3 | 2017 | 3315 | 0.040 |
Why?
| Intussusception | 2 | 2013 | 28 | 0.040 |
Why?
| Ultrasonography, Doppler | 1 | 2000 | 104 | 0.040 |
Why?
| Tetanus Toxoid | 2 | 2012 | 37 | 0.040 |
Why?
| New York | 1 | 2020 | 105 | 0.040 |
Why?
| Fetal Growth Retardation | 1 | 2004 | 470 | 0.040 |
Why?
| Pandemics | 2 | 2021 | 1311 | 0.040 |
Why?
| Colorectal Neoplasms | 1 | 2005 | 592 | 0.040 |
Why?
| Age Distribution | 2 | 2013 | 341 | 0.040 |
Why?
| Infant Formula | 2 | 2010 | 74 | 0.040 |
Why?
| Blood Flow Velocity | 1 | 2000 | 387 | 0.040 |
Why?
| Outpatient Clinics, Hospital | 2 | 2011 | 80 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2017 | 1791 | 0.040 |
Why?
| Serogroup | 1 | 2018 | 27 | 0.040 |
Why?
| Pilot Projects | 2 | 2015 | 1361 | 0.040 |
Why?
| Pharmacists | 1 | 2021 | 231 | 0.040 |
Why?
| Comorbidity | 2 | 2013 | 1447 | 0.040 |
Why?
| Patient Discharge | 1 | 2004 | 770 | 0.040 |
Why?
| Hospital Charges | 1 | 2018 | 39 | 0.040 |
Why?
| HLA Antigens | 2 | 1996 | 220 | 0.040 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2018 | 60 | 0.040 |
Why?
| Morbidity | 1 | 2019 | 277 | 0.040 |
Why?
| Diphtheria | 1 | 2017 | 20 | 0.040 |
Why?
| Tetanus | 1 | 2017 | 25 | 0.040 |
Why?
| Chest Pain | 1 | 2018 | 82 | 0.040 |
Why?
| Awareness | 1 | 2018 | 93 | 0.040 |
Why?
| Whooping Cough | 1 | 2017 | 48 | 0.040 |
Why?
| Immunization, Secondary | 2 | 2010 | 82 | 0.040 |
Why?
| Population Groups | 1 | 2017 | 55 | 0.040 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2020 | 222 | 0.040 |
Why?
| Demography | 2 | 2008 | 258 | 0.030 |
Why?
| Healthy Lifestyle | 1 | 2017 | 30 | 0.030 |
Why?
| Transplantation Immunology | 1 | 2017 | 30 | 0.030 |
Why?
| Cost of Illness | 1 | 2018 | 255 | 0.030 |
Why?
| Lipoproteins, LDL | 1 | 2017 | 127 | 0.030 |
Why?
| Professional Practice Gaps | 1 | 2016 | 9 | 0.030 |
Why?
| Health Plan Implementation | 1 | 2018 | 132 | 0.030 |
Why?
| Altitude | 1 | 2000 | 435 | 0.030 |
Why?
| Palivizumab | 1 | 2016 | 13 | 0.030 |
Why?
| Blood Pressure Determination | 1 | 2017 | 122 | 0.030 |
Why?
| Milk Proteins | 1 | 1996 | 36 | 0.030 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 1996 | 3254 | 0.030 |
Why?
| Administration, Oral | 1 | 1998 | 725 | 0.030 |
Why?
| Liver Failure | 1 | 2016 | 73 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2017 | 384 | 0.030 |
Why?
| Focus Groups | 1 | 2017 | 379 | 0.030 |
Why?
| Contrast Media | 1 | 2018 | 347 | 0.030 |
Why?
| Milk | 1 | 1996 | 123 | 0.030 |
Why?
| Equipment and Supplies | 1 | 2015 | 38 | 0.030 |
Why?
| Exercise Test | 1 | 2018 | 547 | 0.030 |
Why?
| Pragmatic Clinical Trials as Topic | 1 | 2015 | 47 | 0.030 |
Why?
| Mass Screening | 2 | 2005 | 979 | 0.030 |
Why?
| Canada | 1 | 2016 | 320 | 0.030 |
Why?
| Pulse Wave Analysis | 1 | 2016 | 207 | 0.030 |
Why?
| Immunocompromised Host | 1 | 2017 | 192 | 0.030 |
Why?
| Triglycerides | 1 | 2017 | 467 | 0.030 |
Why?
| Retreatment | 1 | 2015 | 67 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2015 | 116 | 0.030 |
Why?
| Heart Rate | 1 | 2018 | 710 | 0.030 |
Why?
| Ventricular Outflow Obstruction | 1 | 2015 | 38 | 0.030 |
Why?
| Graft Survival | 1 | 2017 | 443 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2021 | 2388 | 0.030 |
Why?
| Communication | 1 | 2019 | 733 | 0.030 |
Why?
| Cluster Analysis | 1 | 2015 | 452 | 0.030 |
Why?
| Unemployment | 1 | 2014 | 39 | 0.030 |
Why?
| Decision Support Systems, Clinical | 1 | 2016 | 175 | 0.030 |
Why?
| Bisexuality | 1 | 2013 | 17 | 0.030 |
Why?
| Consumer Behavior | 1 | 2014 | 65 | 0.030 |
Why?
| Homosexuality, Female | 1 | 2013 | 25 | 0.030 |
Why?
| Societies, Medical | 1 | 2017 | 655 | 0.030 |
Why?
| Graft Rejection | 1 | 2017 | 511 | 0.030 |
Why?
| Unsafe Sex | 1 | 2013 | 57 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 1690 | 0.030 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 373 | 0.030 |
Why?
| Circovirus | 1 | 2013 | 7 | 0.030 |
Why?
| Social Behavior | 1 | 2015 | 267 | 0.030 |
Why?
| Autoimmune Diseases | 1 | 1996 | 381 | 0.030 |
Why?
| Community Mental Health Services | 1 | 2013 | 82 | 0.030 |
Why?
| Housing | 1 | 2014 | 114 | 0.030 |
Why?
| Qualitative Research | 1 | 2017 | 924 | 0.030 |
Why?
| Hospital Mortality | 1 | 1997 | 773 | 0.030 |
Why?
| Sex Distribution | 1 | 2013 | 336 | 0.030 |
Why?
| Interdisciplinary Communication | 1 | 2014 | 183 | 0.030 |
Why?
| Drug Contamination | 1 | 2013 | 51 | 0.030 |
Why?
| Product Surveillance, Postmarketing | 1 | 2013 | 63 | 0.030 |
Why?
| Homosexuality, Male | 1 | 2013 | 169 | 0.030 |
Why?
| Patient Compliance | 2 | 2012 | 524 | 0.020 |
Why?
| Databases, Factual | 1 | 2017 | 1127 | 0.020 |
Why?
| Autoantibodies | 2 | 1996 | 1350 | 0.020 |
Why?
| Self Report | 1 | 2016 | 695 | 0.020 |
Why?
| Community-Institutional Relations | 1 | 2012 | 89 | 0.020 |
Why?
| Double-Blind Method | 1 | 2015 | 1656 | 0.020 |
Why?
| Interpersonal Relations | 1 | 2014 | 339 | 0.020 |
Why?
| Autoimmunity | 1 | 1996 | 815 | 0.020 |
Why?
| Pharmaceutical Services | 1 | 2011 | 76 | 0.020 |
Why?
| Cholesterol, LDL | 1 | 2012 | 307 | 0.020 |
Why?
| Hospitals, Teaching | 1 | 2011 | 102 | 0.020 |
Why?
| Swine | 1 | 2013 | 687 | 0.020 |
Why?
| Fees, Pharmaceutical | 1 | 2010 | 13 | 0.020 |
Why?
| Fees, Medical | 1 | 2009 | 9 | 0.020 |
Why?
| Gestational Age | 2 | 2004 | 761 | 0.020 |
Why?
| Drug Utilization | 1 | 2011 | 164 | 0.020 |
Why?
| Electronic Health Records | 1 | 2016 | 801 | 0.020 |
Why?
| Multilingualism | 1 | 2009 | 26 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2012 | 1117 | 0.020 |
Why?
| Caregivers | 2 | 2006 | 714 | 0.020 |
Why?
| Urban Health Services | 1 | 2009 | 60 | 0.020 |
Why?
| Telephone | 1 | 2010 | 152 | 0.020 |
Why?
| Community-Based Participatory Research | 1 | 2009 | 129 | 0.020 |
Why?
| Blood Glucose | 1 | 2017 | 1827 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2015 | 2764 | 0.020 |
Why?
| Epidemiologic Research Design | 1 | 2008 | 27 | 0.020 |
Why?
| Diabetes Complications | 1 | 2009 | 208 | 0.020 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2009 | 133 | 0.020 |
Why?
| Single-Blind Method | 1 | 2008 | 259 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2012 | 1837 | 0.020 |
Why?
| Health Care Rationing | 1 | 2007 | 45 | 0.020 |
Why?
| Psychology | 1 | 2008 | 82 | 0.020 |
Why?
| Vascular Diseases | 1 | 2009 | 233 | 0.020 |
Why?
| Office Visits | 1 | 2006 | 79 | 0.020 |
Why?
| Glomerular Filtration Rate | 1 | 2009 | 605 | 0.020 |
Why?
| Biomarkers | 2 | 2012 | 3397 | 0.020 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 1996 | 44 | 0.020 |
Why?
| Glutamate Decarboxylase | 2 | 1996 | 160 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2010 | 666 | 0.020 |
Why?
| Insulin Antibodies | 2 | 1996 | 102 | 0.020 |
Why?
| Psychosocial Deprivation | 1 | 2005 | 5 | 0.020 |
Why?
| Protein Tyrosine Phosphatases | 2 | 1996 | 147 | 0.020 |
Why?
| Health Behavior | 1 | 2011 | 701 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2009 | 1162 | 0.020 |
Why?
| Urban Health | 1 | 2005 | 73 | 0.020 |
Why?
| Rural Health | 1 | 2005 | 67 | 0.010 |
Why?
| Medical Staff, Hospital | 1 | 2005 | 74 | 0.010 |
Why?
| Prostatectomy | 1 | 2005 | 97 | 0.010 |
Why?
| Mass Media | 1 | 2005 | 37 | 0.010 |
Why?
| Karnofsky Performance Status | 1 | 2004 | 36 | 0.010 |
Why?
| Internship and Residency | 1 | 2013 | 920 | 0.010 |
Why?
| Time and Motion Studies | 1 | 2004 | 20 | 0.010 |
Why?
| Brachytherapy | 1 | 2005 | 100 | 0.010 |
Why?
| Biometry | 1 | 2004 | 62 | 0.010 |
Why?
| Perception | 1 | 2007 | 309 | 0.010 |
Why?
| Feeding Behavior | 1 | 2009 | 572 | 0.010 |
Why?
| Probability | 1 | 2005 | 286 | 0.010 |
Why?
| Ohio | 1 | 2004 | 135 | 0.010 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2007 | 239 | 0.010 |
Why?
| Body Size | 1 | 2004 | 90 | 0.010 |
Why?
| Professional-Patient Relations | 1 | 2005 | 140 | 0.010 |
Why?
| Smoking | 1 | 2011 | 1382 | 0.010 |
Why?
| Policy Making | 1 | 2004 | 80 | 0.010 |
Why?
| Eligibility Determination | 1 | 2004 | 59 | 0.010 |
Why?
| Patient Care | 1 | 2004 | 99 | 0.010 |
Why?
| Femur | 1 | 2004 | 191 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2011 | 2540 | 0.010 |
Why?
| Recurrence | 1 | 2005 | 925 | 0.010 |
Why?
| Mortality | 1 | 2004 | 283 | 0.010 |
Why?
| Apgar Score | 1 | 2001 | 16 | 0.010 |
Why?
| Bone and Bones | 1 | 2004 | 277 | 0.010 |
Why?
| Perineum | 1 | 2001 | 25 | 0.010 |
Why?
| Suction | 1 | 2001 | 31 | 0.010 |
Why?
| Endpoint Determination | 1 | 2001 | 68 | 0.010 |
Why?
| Delivery, Obstetric | 1 | 2001 | 118 | 0.010 |
Why?
| Umbilical Cord | 1 | 2000 | 80 | 0.010 |
Why?
| Private Sector | 1 | 2000 | 51 | 0.010 |
Why?
| Exercise | 1 | 2009 | 1641 | 0.010 |
Why?
| Patient Readmission | 1 | 2004 | 607 | 0.010 |
Why?
| Arteries | 1 | 2000 | 246 | 0.010 |
Why?
| Birth Weight | 1 | 2000 | 439 | 0.010 |
Why?
| Acute Disease | 1 | 2000 | 909 | 0.010 |
Why?
| Histocompatibility Testing | 1 | 1996 | 115 | 0.010 |
Why?
| Infant Food | 1 | 1996 | 63 | 0.010 |
Why?
| Quality Control | 1 | 1996 | 143 | 0.010 |
Why?
| HLA-DQ Antigens | 1 | 1996 | 174 | 0.010 |
Why?
| Dietary Proteins | 1 | 1996 | 121 | 0.010 |
Why?
| HLA-DR Antigens | 1 | 1996 | 219 | 0.010 |
Why?
| DNA Primers | 1 | 1996 | 508 | 0.010 |
Why?
| Fetal Blood | 1 | 1996 | 268 | 0.010 |
Why?
| Alleles | 1 | 1996 | 789 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1996 | 990 | 0.010 |
Why?
| Survival Analysis | 1 | 1996 | 1206 | 0.010 |
Why?
| Genotype | 1 | 1996 | 1757 | 0.010 |
Why?
|
|
Beaty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|